Medicine,
Год журнала:
2024,
Номер
103(31), С. e39134 - e39134
Опубликована: Авг. 2, 2024
Background:
Irritable
bowel
syndrome
(IBS)
is
a
major
global
healthcare
burden
that
requires
effective
and
well-tolerated
intervention.
This
study
aimed
to
investigate
the
effectiveness
safety
of
Bacillus
coagulans
BCP92,
probiotic,
in
managing
IBS
symptoms.
Methods:
randomized
controlled
trial
included
100
participants
who
strictly
adhered
protocol.
Various
parameters
such
as
severity,
digestive
symptom
frequency,
gastrointestinal
stool
consistency,
interleukin-6
levels,
stress
relief,
anxiety
levels
were
evaluated
over
12
weeks.
Results:
B.
BCP92
significantly
improved
severity
(
P
<
.001),
frequency
.001)
compared
with
control
group.
The
consistency
.001).
Mental
relief
was
remarkable
=
differentiating
test
groups.
No
significant
change
observed;
however,
assessment
revealed
an
excellent
profile
no
reported
severe
adverse
events.
Conclusion:
one
most
promising
therapeutic
options
for
management
because
it
has
shown
efficacy
alleviating
symptoms
among
patients
suffering
from
this
condition,
resulting
changes
addition
improving
overall
mental
well-being
its
users,
thereby
foreseeing
elimination
any
potential
side
effects
experienced
during
implementation
approach
strategy
within
our
health
care
system,
patient
outcomes
leading
individualization
treatment
plans
all
individuals
diagnosed
disease
entity
may
have
symptoms,
including
abdominal
pain
or
discomfort
associated
habits.
Frontiers in Pharmacology,
Год журнала:
2022,
Номер
13
Опубликована: Янв. 25, 2022
Functional
gastrointestinal
disorders
(FGIDs)
have
been
re-named
as
of
gut-brain
interactions.
These
conditions
are
not
only
common
in
clinical
practice,
but
also
the
community.
In
reference
to
Rome
IV
criteria,
most
FGIDs,
include
functional
dyspepsia
(FD)
and
irritable
bowel
syndrome
(IBS).
Additionally,
there
is
substantial
overlap
these
other
specific
motility
disorders,
such
gastroparesis.
heterogeneous
intertwined
with
several
proposed
pathophysiological
mechanisms,
altered
gut
motility,
intestinal
barrier
dysfunction,
immune
visceral
hypersensitivity,
GI
secretion,
presence
degree
bile
acid
malabsorption,
microbial
dysbiosis,
alterations
axis.
The
treatment
options
currently
available
lifestyle
modifications,
dietary
microbiota
manipulation
interventions
including
fecal
transplantation,
prokinetics,
antispasmodics,
laxatives,
centrally
peripherally
acting
neuromodulators.
However,
that
targets
mechanisms
underlying
symptoms
scanty.
Pharmacological
agents
developed
based
on
cellular
molecular
pathologies
might
provide
best
avenue
for
future
pharmaceutical
development.
therapies
lack
long-term
effectiveness
safety
their
use
treat
FGIDs.
Furthermore,
fundamental
challenges
treating
should
be
defined;
instance,
1.
Cause
effect
cannot
disentangled
between
due
current
entail
off-label
medications
symptoms.
2.
Despite
knowledge
our
plays
an
essential
part
maintaining
health,
exact
functions
homeostasis
still
unclear.
What
constitutes
a
healthy
microbiome
further,
precise
definition
dysbiosis
lacking.
More
comprehensive,
large-scale,
longitudinal
studies
utilizing
multi-omics
data
needed
dissect
contribution
disease
pathogenesis.
Accordingly,
we
review
options,
insight
pathophysiology,
therapeutic
modalities,
challenges,
clues
care
management
dyspepsia,
gastroparesis,
syndrome,
constipation,
diarrhea.
Microorganisms,
Год журнала:
2023,
Номер
11(9), С. 2177 - 2177
Опубликована: Авг. 29, 2023
The
gut
microbiota
represents
a
community
of
microorganisms
(bacteria,
fungi,
archaea,
viruses,
and
protozoa)
that
colonize
the
are
responsible
for
mucosal
structural
integrity
immune
metabolic
homeostasis.
relationship
between
microbiome
human
health
has
been
intensively
researched
in
past
years.
It
is
now
widely
recognized
microbial
composition
highly
general
host.
Among
diseases
have
linked
to
an
altered
population
diarrheal
illnesses
functional
constipation.
capacity
probiotics
modulate
population,
strengthen
intestinal
barrier,
system
together
with
their
antioxidant
properties
encouraged
research
probiotic
therapy
many
gastrointestinal
afflictions.
Dietary
lifestyle
changes
use
seem
play
important
role
easing
constipation
effectively
alleviating
diarrhea
by
suppressing
germs
involved.
This
review
aims
describe
how
bacteria
specific
strains
could
interfere
bring
benefits
as
associated
treatment
Microorganisms,
Год журнала:
2023,
Номер
11(5), С. 1122 - 1122
Опубликована: Апрель 25, 2023
Gastroparesis
(GP)
is
a
disorder
of
gastric
functions
that
defined
by
objective
delayed
emptying
in
the
absence
mechanical
obstruction.
This
disease
characterized
symptoms
such
as
nausea,
post-prandial
fullness,
and
early
satiety.
GP
significantly
impacts
patients’
quality
life
contributes
to
substantial
healthcare
expenses
for
families
society.
However,
epidemiological
burden
difficult
evaluate,
mainly
due
its
significant
overlap
with
functional
dyspepsia
(FD).
FD
represent
two
similar
diseases.
The
pathophysiology
both
disorders
involves
abnormal
motility,
visceral
hypersensitivity,
mucosal
inflammation.
Moreover,
conditions
share
symptoms,
epigastric
pain,
bloating,
latest
evidence
reveals
dysbiosis
directly
or
indirectly
connected
gut–brain
axis
alterations,
which
are
basis
pathogenesis
GP.
Furthermore,
role
microbiota
development
gastroparesis
was
demonstrated
some
clinical
studies,
found
use
probiotics
correlated
improvements
time
(GET).
Infections
(with
viruses,
bacteria,
protozoa)
proven
etiology
but
have
not
been
sufficiently
considered
current
practice.
Previous
viral
infections
can
be
about
20%
idiopathic
cases.
during
systemic
protozoal
represents
huge
concern
compromised
patients,
few
data
exist
on
topic.
comprehensive
narrative
review
analyzes
relationship
between
microorganisms
We
explore,
one
hand,
correlation
gut
pathogenesis,
including
treatment
implications,
and,
other
association
exogenous
disease.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(15), С. 8250 - 8250
Опубликована: Июль 28, 2024
The
intricate
relationship
between
the
gastrointestinal
(GI)
microbiome
and
progression
of
chronic
non-communicable
diseases
underscores
significance
developing
strategies
to
modulate
GI
microbiota
for
promoting
human
health.
administration
probiotics
prebiotics
represents
a
good
strategy
that
enhances
population
beneficial
bacteria
in
intestinal
lumen
post-consumption,
which
has
positive
impact
on
In
addition,
dietary
fibers
serve
as
significant
energy
source
inhabiting
cecum
colon.
Research
articles
reviews
sourced
from
various
global
databases
were
systematically
analyzed
using
specific
phrases
keywords
investigate
these
relationships.
There
is
clear
association
fiber
intake
improved
colon
function,
gut
motility,
reduced
colorectal
cancer
(CRC)
risk.
Moreover,
state
health
reflected
reciprocal
bidirectional
relationships
among
food,
antioxidants,
inflammation,
body
composition.
They
are
known
their
antioxidant
properties
ability
inhibit
angiogenesis,
metastasis,
cell
proliferation.
Additionally,
they
promote
survival,
immune
inflammatory
responses,
inactivate
pro-carcinogens.
These
actions
collectively
contribute
role
prevention.
different
investigations,
supplements
containing
vitamins
have
been
shown
lower
risk
types.
contrast,
some
evidence
suggests
taking
can
increase
cancer.
Ultimately,
collaborative
efforts
immunologists,
clinicians,
nutritionists,
dietitians
imperative
designing
well-structured
nutritional
trials
corroborate
clinical
efficacy
therapy
managing
inflammation
preventing
carcinogenesis.
This
review
seeks
explore
interrelationships
fiber,
microbiome,
with
particular
focus
potential
implications
Scientific Reports,
Год журнала:
2023,
Номер
13(1)
Опубликована: Сен. 2, 2023
High-throughput
sequencing
allows
for
the
comprehensive
analysis
of
human
intestinal
microbiota.
However,
extensive
association
analyses
between
microbiome
and
lifestyle
differences
in
Chinese
population
are
limited.
Here,
we
carried
out
an
independent
cohort
study-the
Healthy
Gut
Project
(n
=
483)-where
correlations
gut
microbiota
dietary
variables
a
healthy
defined.
We
collected
both
questionnaire
data,
including
basic
information
variables,
fecal
stools
from
enrolled
volunteers.
then
performed
16S
rRNA
on
microbial
DNA
isolated
to
assess
composition
found
that
Prevotella
Bacteroides
were
most
abundant
genera
microbiome.
Additionally,
9
29
clinical
questionnaire-based
phenotype
covariates
be
associated
with
variation
Among
these
phenotypes,
sleep
procrastination,
negative
mood,
drinking
habits
had
largest
effect
size.
appreciable
urbanization
was
observed,
resulting
decreased
intra-individual
diversity,
increased
inter-individual
abundance
enterotype.
The
results
this
study
provide
foundation
assessing
community
structure
at
baseline
population.
Furthermore,
also
provides
insights
into
understanding
how
distinctive
living
influence
relationships
systemic
health
state.
Biomedicines,
Год журнала:
2023,
Номер
11(3), С. 748 - 748
Опубликована: Март 1, 2023
The
prevalence
of
neurological
conditions
which
manifest
with
chronic
pain
is
increasing
globally,
where
the
World
Health
Organisation
has
now
classified
as
a
risk
factor
for
death
by
suicide.
While
many
have
definitive
underlying
aetiology,
non-somatic
represent
difficult-to-diagnose
and
difficult-to-treat
public
health
issues.
interaction
immune
system
nervous
become
an
important
area
in
understanding
occurrence
neuroinflammation,
nociception,
peripheral
central
sensitisation
seen
pain.
More
recently,
however,
role
resident
microbial
species
human
gastrointestinal
tract
evident.
Dysbiosis,
alteration
present
favour
non-beneficial
pathogenic
emerged
conditions,
including
functional
somatic
syndromes,
autoimmune
disease
diseases.
In
particular,
decreased
abundance
small
chain
fatty
acid,
e.g.,
butyrate-producing
bacteria,
Faecalibacterium,
Firmicutes
some
Bacteroides
spp.,
frequently
evident
morbidities
associated
long-term
Microbes
involved
production
neurotransmitters
serotonin,
GABA,
glutamate
dopamine,
mediate
gut-brain,
axis
are
also
important.
This
review
outlines
dysbiosis
states
manifesting
pain,
overlap
patients.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(23), С. 16660 - 16660
Опубликована: Ноя. 23, 2023
Autism
spectrum
disorder
(ASD)
is
a
complex
neurodevelopmental
condition
characterized
by
several
core
symptoms:
restricted
interests,
communication
difficulties,
and
impaired
social
interactions.
Many
ASD
children
experience
gastrointestinal
functional
disorders,
impacting
their
well-being.
Emerging
evidence
suggests
that
gut
microbiota
imbalance
may
exacerbate
symptoms.
Our
review
assesses
the
in
with
interventions
targeting
modulation.
The
analysis
of
forty-four
studies
(meta-analyses,
reviews,
original
research)
reveals
insights
into
microbiota-ASD
relationship.
While
specific
alterations
are
mixed,
some
trends
emerge.
exhibit
increased
Firmicutes
(36-81%)
Pseudomonadota
(78%)
decreased
Bacteroidetes
(56%).
to
ratio
tends
be
lower
(56%)
compared
without
ASD,
which
correlates
behavioral
abnormalities.
Probiotics,
particularly
Lactobacillus,
Bifidobacterium,
Streptococcus
strains,
show
promise
alleviating
symptoms
(66%).
Microbiota
transfer
therapy
(MTT)
seems
have
lasting
benefits
for
one
longitudinal
study.
Prebiotics
can
potentially
help
issues,
needing
further
research
conclusive
efficacy
due
different
being
used.
This
highlights
interplay,
offering
potential
therapeutic
avenues
gut-brain
axis.
However,
study
heterogeneity,
small
sample
sizes,
methodological
variations
emphasize
need
comprehensive,
standardized
research.
Future
investigations
unveil
mechanisms
linking
ultimately
enhancing
quality
life
affected
individuals.
Frontiers in Pharmacology,
Год журнала:
2023,
Номер
14
Опубликована: Июнь 1, 2023
Chronic
low-grade
inflammation
affects
health
and
is
associated
with
aging
age-related
diseases.
Dysregulation
of
the
gut
flora
an
important
trigger
for
chronic
inflammation.
Changes
in
composition
exposure
to
related
metabolites
have
effect
on
inflammatory
system
host.
This
results
development
crosstalk
between
barrier
immune
system,
contributing
impairment
health.
Probiotics
can
increase
diversity
microbiota,
protect
barrier,
regulate
immunity,
thereby
reducing
Therefore,
use
probiotics
a
promising
strategy
beneficial
immunomodulation
protection
through
microbiota.
These
processes
might
positively
influence
diseases,
which
are
common
elderly.